Guardian Pharmacy Services (NYSE:GRDN) Shares Down 5.3% – Here’s What Happened

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDNGet Free Report) traded down 5.3% during trading on Friday . The stock traded as low as $19.50 and last traded at $20.48. 46,141 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 153,686 shares. The stock had previously closed at $21.63.

Guardian Pharmacy Services Stock Performance

The company has a fifty day moving average of $20.52.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Management Group LLP purchased a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $8,400,000. Franklin Resources Inc. acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth about $8,575,000. Foundry Partners LLC purchased a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $1,680,000. Barclays PLC acquired a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $311,000. Finally, Maven Securities LTD purchased a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $3,033,000.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

See Also

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.